US Patent 10260051 Phage therapy of
Patent 10260051 was granted and assigned to Pherecydes Pharma on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10260051 Phage therapy of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.